Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
Status:
Not yet recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to evaluate whether testosterone replacement results in greater
improvement in pain perception, pain tolerance, sexual function, fatigue, and quality of life
when compared with placebo in men with chronic back pain treated with opioids who have
opioid-induced hypogonadism (low testosterone).